Company news
Quest PharmaTech Inc. news in 2017
Quest PharmaTech Inc.'s news releases, calls and decks from 2017, newest first.
Quest PharmaTech Announces Results from its November 2017 AGM
November 6, 2017
OncoQuest Announces Collaboration with TESARO in Recurrent Ovarian Cancer Setting
October 26, 2017
Quest PharmaTech Receives $1,666,667 of Funding Proceeds Through Exercise of Warrants
August 28, 2017
First Patient Enrolled in OncoQuest's Phase 1/2 Study Combining Oregovomab with Hiltonol® in Recurrent Ovarian Cancer
July 26, 2017
Quest PharmaTech Appoints Mr. Mark Lievonen, former President of Sanofi Pasteur Limited, to the Board of Directors
July 19, 2017
OncoQuest Appoints Senior Biotech Investment Banker Hany Awadalla as Senior Vice President and Chief Financial Officer
June 27, 2017
OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 24, 2017
Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin(TM) Serum for Anti-Aging
May 18, 2017
OncoQuest Announces Enrollment of First Patient in Phase 1/2 Clinical Study Using Combination of Oregovomab with Checkpoint Inhibitor Nivolumab in Recurrent Ovarian Cancer
May 9, 2017
Quest PharmaTech Expands Its Consumer Health Product Pipeline with Clinically Validated Natural Allergy Relief
May 4, 2017
Quest PharmaTech Announces Results from its 2017 AGM
February 15, 2017